 |
|
Nano-sized technology has super-sized effect on tumors
April 03, 2008Anyone facing chemotherapy would welcome an advance promising to dramatically reduce their dose of these often harsh drugs. Using nanotechnology, researchers at Washington University School of Medicine in St. Louis have taken a step closer to that goal.
The researchers focused a powerful drug directly on tumors in rabbits using drug-coated nanoparticles. They found that a drug dose 1,000 times lower than used previously for this purpose markedly slowed tumor growth.
"Many chemotherapeutic drugs have unwanted side effects, and we've shown that our nanoparticle technology has the potential to increase drug effectiveness and decrease drug dose to alleviate harmful side effects," says lead author Patrick M. Winter, Ph.D., research assistant professor of medicine and biomedical engineering.
The nanoparticles are extremely tiny beads of an inert, oily compound that can be coated with a wide variety of active substances. In an article published online in The FASEB Journal, the researchers describe a significant reduction of tumor growth in rabbits that were treated with nanoparticles coated with a fungal toxin called fumagillin. Human clinical trials have shown that fumagillin can be an effective cancer treatment in combination with other anticancer drugs.
In addition to fumagillin, the nanoparticles' surfaces held molecules designed to stick to proteins found primarily on the cells of growing blood vessels. So the nanoparticles latched on to sites of blood vessel proliferation and released their fumagillin load into blood vessel cells. Fumagillin blocks multiplication of blood vessel cells, so it inhibited tumors from expanding their blood supply and slowed their growth.
Human trials have also shown that fumagillin can have neurotoxic side effects at the high doses required when given by standard methods. But the fumagillin nanoparticles were effective in very low doses because they concentrate where tumors create new blood vessels. The rabbits that received fumagillin nanoparticles showed no adverse side effects.
Senior author Gregory M. Lanza, M.D., Ph.D., associate professor of medicine and of biomedical engineering, and Samuel A. Wickline, M.D., professor of medicine, of physics and of biomedical engineering, are co-inventors of the nanoparticle technology. The nanoparticles measure only about 200 nanometers across, or 500 times smaller than the width of a human hair. Their cores are composed mostly of perfluorocarbon, a safe compound used in artificial blood.
The nanoparticles can be adapted to many different medical applications. In addition to carrying drugs to targeted locations, they can be manufactured to highlight specific targets in magnetic resonance imaging (MRI), nuclear imaging, CT scanning and ultrasound imaging.
In this study, researchers loaded blood-vessel-targeted nanoparticles with MRI contrast agent and were able to make detailed maps of tumor blood vessel growth using standard MRI equipment. The MRI scans showed that blood vessel formation tended to concentrate in limited areas on the surface at one side of tumors instead of dispersing uniformly, which was a surprise.
"Using the blood-vessel targeted nanoparticles, we get a far more complete view of tumor biology than we would get with any other technique," Winter says. "If you followed a tumor over a period of time with the nanoparticles and MRI scans, you would have a much better understanding of the tumor's reaction to treatment."
The researchers say they believe nanoparticle technology will be very useful for monitoring cancer treatment results in both the short and long term.
"It gives you a way of determining whether you should continue treatment, change the dose or even try a different treatment altogether," Lanza says.
Prior work has shown that the nanoparticles can be loaded with many kinds of drugs. The researchers used fumagillin nanoparticles in these experiments to demonstrate the feasibility of this approach, but they plan further investigations with other versions of the nanoparticles.
"What this report clearly demonstrates is that our nanoparticles can carry chemotherapeutic drugs specifically to tumors and have an effect at the tumor site," Lanza says. "Sometimes when I give presentations about our nanotechnology, people react as if it was science fiction or at best a technology of the distant future. But we've shown that the technology is ready for medical applications now."
The nanoparticles will be tested this year in preliminary human clinical trials to determine the optimal method for using them as imaging agents. These studies will lay essential groundwork for using the nanoparticles as therapeutic agents.
Washington University School of Medicine
The nanoparticles are extremely tiny beads of an inert, oily compound that can be coated with a wide variety of active substances. In an article published online in The FASEB Journal, the researchers describe a significant reduction of tumor growth in rabbits that were treated with nanoparticles coated with a fungal toxin called fumagillin. Human clinical trials have shown that fumagillin can be an effective cancer treatment in combination with other anticancer drugs.
In addition to fumagillin, the nanoparticles' surfaces held molecules designed to stick to proteins found primarily on the cells of growing blood vessels. So the nanoparticles latched on to sites of blood vessel proliferation and released their fumagillin load into blood vessel cells. Fumagillin blocks multiplication of blood vessel cells, so it inhibited tumors from expanding their blood supply and slowed their growth.
Human trials have also shown that fumagillin can have neurotoxic side effects at the high doses required when given by standard methods. But the fumagillin nanoparticles were effective in very low doses because they concentrate where tumors create new blood vessels. The rabbits that received fumagillin nanoparticles showed no adverse side effects.
Senior author Gregory M. Lanza, M.D., Ph.D., associate professor of medicine and of biomedical engineering, and Samuel A. Wickline, M.D., professor of medicine, of physics and of biomedical engineering, are co-inventors of the nanoparticle technology. The nanoparticles measure only about 200 nanometers across, or 500 times smaller than the width of a human hair. Their cores are composed mostly of perfluorocarbon, a safe compound used in artificial blood.
The nanoparticles can be adapted to many different medical applications. In addition to carrying drugs to targeted locations, they can be manufactured to highlight specific targets in magnetic resonance imaging (MRI), nuclear imaging, CT scanning and ultrasound imaging.
In this study, researchers loaded blood-vessel-targeted nanoparticles with MRI contrast agent and were able to make detailed maps of tumor blood vessel growth using standard MRI equipment. The MRI scans showed that blood vessel formation tended to concentrate in limited areas on the surface at one side of tumors instead of dispersing uniformly, which was a surprise.
"Using the blood-vessel targeted nanoparticles, we get a far more complete view of tumor biology than we would get with any other technique," Winter says. "If you followed a tumor over a period of time with the nanoparticles and MRI scans, you would have a much better understanding of the tumor's reaction to treatment."
The researchers say they believe nanoparticle technology will be very useful for monitoring cancer treatment results in both the short and long term.
"It gives you a way of determining whether you should continue treatment, change the dose or even try a different treatment altogether," Lanza says.
Prior work has shown that the nanoparticles can be loaded with many kinds of drugs. The researchers used fumagillin nanoparticles in these experiments to demonstrate the feasibility of this approach, but they plan further investigations with other versions of the nanoparticles.
"What this report clearly demonstrates is that our nanoparticles can carry chemotherapeutic drugs specifically to tumors and have an effect at the tumor site," Lanza says. "Sometimes when I give presentations about our nanotechnology, people react as if it was science fiction or at best a technology of the distant future. But we've shown that the technology is ready for medical applications now."
The nanoparticles will be tested this year in preliminary human clinical trials to determine the optimal method for using them as imaging agents. These studies will lay essential groundwork for using the nanoparticles as therapeutic agents.
Washington University School of Medicine
Nanoparticles Current Events and Nanoparticles News RSSChemists describe solar energy progress and challenges, including the 'artificial leaf'
Scientists are making progress toward development of an "artificial leaf" that mimics a real leaf's chemical magic with photosynthesis - but instead converts sunlight and water into a liquid fuel such as methanol for cars and trucks.
Magnetic nanoparticles to simultaneously diagnose, monitor and treat
Whether it's magnetic nanoparticles (mNPs) giving an army of 'therapeutically armed' white blood cells direction to invade a deadly tumour's territory, or the use of mNPs to target specific nerve channels and induce nerve-led behaviour (such as the life-dependant thumping of our hearts), mNPs have come a long way in the past decade.
An exquisite container
In campy old movies, Lucretia Borgia swans around emptying powder from her ring into wine glasses carelessly left unattended. The poison ring is usually a confection of gold filigree holding a cabochon or faceted gemstone that can be broken to empty the ring's contents. It is invariably enormous - so large it is rather odd nobody seems to notice it.
Hard Rain: Pitt-led Researchers Create Nano-Particle Coating to Prevent Freezing Rain Buildup on Roads, Power Lines
Preventing the havoc wrought when freezing rain collects on roads, power lines, and aircrafts could be only a few nanometers away.
Knocking nanoparticles off the socks
Scientists in Switzerland are reporting results of one of the first studies on the release of silver nanoparticles from laundering those anti-odor, anti-bacterial socks now on the market.
Magnetic mixing creates quite a stir
Sandia researchers have developed a process that can mix tiny volumes of liquid, even in complicated spaces.
Nanowire biocompatibility in the brain: So far so good
The biological safety of nanotechnology, in other words, how the body reacts to nanoparticles, is a hot topic. Researchers at Lund University in Sweden have managed for the first time to carry out successful experiments involving the injection of so-called 'nanowires.'
Berkeley Researchers Find New Route to Nano Self-Assembly
If the promise of nanotechnology is to be fulfilled, nanoparticles will have to be able to make something of themselves. An important advance towards this goal has been achieved by researchers with the U.S. Department of Energy's Lawrence Berkeley National Laboratory (Berkeley Lab) who have found a simple and yet powerfully robust way to induce nanoparticles to assemble themselves into complex arrays.
Advance in 'nano-agriculture': Tiny stuff has huge effect on plant growth
With potential adverse health and environmental effects often in the news about nanotechnology, scientists in Arkansas are reporting that carbon nanotubes (CNTs) could have beneficial effects in agriculture.
Nanotech protection
Writing in a forthcoming issue of the International Journal of Nanotechnology, Canadian engineers suggest that research is needed into the risks associated with the growing field of nanotechnology manufacture so that appropriate protective equipment can be developed urgently.
More Nanoparticles Current Events and Nanoparticles News Articles
 |
Nanoparticles: From Theory to Application by Günter Schmid (Editor) An introduction to the science of nanoparticles, from fundamental principles to their use in novel applications. As a basis for understanding nanoparticle behavior, the book first outlines the principles of quantum size behavior, nanoparticles architecture, formation of semiconductor and metal nanoparticles. It then goes on to describe the chemical syntheses of nanoparticles with defined characteristics, their structural, electrical and magnetic properties, as well as current methods to monitor these properties. Among others, the following nanoparticle-based applications are discussed: * Single-electron devices * Ultra dense recording media * Bioelectronic devices and sensors * Labeling of proteins, nucleic acids and other biomaterials. ... |
 |
Nanoparticle Technology Handbook by Masuo Hosokawa (Editor), Kiyoshi Nogi (Editor), Makio Naito (Editor), Toyokazu Yokoyama (Editor) Nanoparticle technology, which handles the preparation, processing, application and characterisation of nanoparticles, is a new and revolutionary technology. It becomes the core of nanotechnology as an extension of the conventional Fine Particle / Powder Technology. Nanoparticle technology plays an important role in the implementation of nanotechnology in many engineering and industrial fields including electronic devices, advanced ceramics, new batteries, engineered catalysts, functional paint and ink, Drug Delivery System, biotechnology, etc.; and makes use of the unique properties of the nanoparticles which are completely different from those of the bulk materials. This new handbook is the first to explain complete aspects of nanoparticles with many application examples showing... |
 |
Nanoparticles: Building Blocks for Nanotechnology (Nanostructure Science and Technology) by Vincent Rotello (Author) The diverse structures and properties of nanoparticles make them useful tools for both fundamental studies and pragmatic applications in a range of disciplines. This volume is intended to explore this diversity. The first section covers on formation of nanoparticles, and assembly of these systems into structured systems. The second section focuses on both the fundamental physical properties of nanoparticles and pragmatic applications of these systems in the areas of device and materials fabrication. The book will approach the subject from a chemical standpoint, in contrast to most books which are oriented towards materials science or physics. It will also appeal to materials scientists and physicists who are becoming aware of the contributions that chemists can make here. |
 |
Metal Nanoparticles: Synthesis Characterization & Applications by Daniel L. Feldheim (Author) Offers the latest research on the synthesis, characterization, and applications of nanoparticle structural, optical, and electronic properties. |
|
International Journal of Nanoparticles by Inderscience Enterprises Ltd | |
 |
Synthesis, Functionalization and Surface Treatment of Nanoparticles by Marie-Isabelle Baraton (Author) Synthesis, functionalization and surface treatment of nanoparticles is an area of crucial importance in the emerging field of nanotechnology. Controlling the surface chemical composition and mastering its modification at the nanometer scale are critical issues for high-added value applications involving nanoparticles. The basic applications of surface functionalization range from altering the wetting or adhesion characteristics and improving the nanoparticles dispersion in matrices to enhancing the catalytic properties and ordering the interfacial region, and such. The creation of specific surface sites on nanoparticles for selective molecular attachment is considered a promising approach for their applications in nanofabrication, nanopatterning, selfassembly, nanosensors, bioprobes, drug... |
 |
Creme De Jour Tinted by Marie Veronique Organics zinc oxide sunscreen no harmful chemicals no nanoparticles |
 |
Nanoparticles and Catalysis by Didier Astruc (Editor) Written by international experts, this monograph combines two of the most important aspects of modern chemistry, presenting the latest knowledge on these environmental friendly applications. This result is a comprehensive overview of the application of nanoparticles in catalysis, focusing on synthesis and the most important reaction types, providing all the information needed by catalytic, organic and solid state chemists, as well as those working with or on organometallics, materials scientists, and chemists in industry. |
 |
Nanoparticles Synthesis, Stabillization, passivation and Functionalization (Acs Symposium Series) by Ramanathan Nagarajan (Editor), T. Alan Hatton (Editor) Recent advances in the synthesis, stabilization, passivation and functionalization of a wide range of metal, metal oxide, semiconductor and other inorganic, polymer, organic, carbon and biological nanoparticles are reported in this book. Diverse shapes of nanoparticles are discussed here including spheres, cubes, nanorods, nanowires, nanotubes, nanocapsules, and nanopyramids. In the section on metals, one can find description of colloidal and wet chemical approaches to synthesize nanoparticles, methods to control number of functional groups and to attain aqueous dispersibility, impact of stabilizers on SERS activity, and ways to tune plasmon resonance via nanoparticle shapes. A time dependent density functional theory to evaluate adsorption properties of passivating ligands is also... |
 |
60 Minutes - The Kanzius Machine (April 13, 2008) Airdate: 04/13/08 John Kanzius has no medical degree. In fact, he doesn't even have a college degree. But Kanzius does have terminal cancer, and that has motivated him to invent a radio-wave machine with the idea of treating cancer without the debilitating side effects of chemotherapy and radiation. Lesley Stahl tells this remarkable story of a leukemia patient so moved by the suffering of children with cancer that he has devoted himself to finding a cure. This product is manufactured on demand using DVD-R recordable media. Amazon.com's standard return policy will apply. |
| © 2009 BrightSurf.com |